This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Arrowhead Research Corp (ARWR)

NASDAQ: Health Care

Company Cash Flow
Sep 2014 Sep 2013 Sep 2012 Sep 2011
Cash Flow From Operating Activities
Net Income (Loss) -58.63M -31.70M -21.13M -3.49M
Operating Gains/Losses -113.04K 76.39K -198.49K 424.40K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 49.13K -64.55K -775.32K -736.25K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets -13.29K -1.81K -6.85K 18.47K
(Decrease) Increase In Payables 1.41M 321.65K 291.88K 157.08K
(Decrease) Increase In Other Current Liabilities 3.48M 27.92K 1.07M 468.59K
(Increase) Decrease In Other Working Capital 94.26K -187.91K -23.75K 0.00
Other Non-Cash Items 16.18M 10.57M 4.01M -4.85M
Net Cash From Continuing Operations -35.42M -19.03M -15.34M -7.66M
Net Cash From Discontinued Operations 0.00 -354.00 -280.00 2.27M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -35.42M -19.03M -15.34M -5.39M
Sale of Property, Plant & Equipment 10.00K 89.50K 290.31K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.72M -296.88K -479.71K -9.67K
Acquisitions 0.00 0.00 121.03K -1.70M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -36.48M -9.52M 440.64K -175.38K
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 12.88M 0.00 10.97M 6.23M
Repayment of Long-Term Debt -225.41K -214.80K -196.61K 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 172.64M 44.51M 0.00 0.00
Net Cash From Financing Activities 185.29M 44.29M 10.77M 6.23M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 113.40M 15.74M -4.13M 660.23K

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ARWR Arrowhead Research Corp

Chart of ARWR

Analysts Ratings for ARWR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

ARWR Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs